Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

APROCITENTAN vs SPARSENTAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

APROCITENTAN vs SPARSENTAN: Safety Overview

Metric APROCITENTAN SPARSENTAN
Total FAERS Reports 10 3,280
Deaths Reported 0 18
Death Rate N/A 0.5%
Hospitalizations 3 209
Average Patient Age 61.0 yrs 49.3 yrs
% Female Patients 36.4% 43.8%
FDA Approval Date Mar 19, 2024 Feb 17, 2023
Manufacturer Idorsia Pharmaceuticals Ltd Travere Therapeutics, Inc.
Route ORAL ORAL
Marketing Status Prescription Prescription